MeSH term
Frequency | Condition_Probility | Aged | 16 | 0.0 |
Humans | 289 | 0.0 |
Risk | 2 | 0.0 |
Time Factors | 18 | 0.0 |
Aged, 80 and over | 9 | 0.0 |
Female | 55 | 0.0 |
Databases | 2 | 2.0 |
Genes, Reporter | 21 | 1.0 |
Luciferases/metabolism | 8 | 1.0 |
Models, Biological | 12 | 0.0 |
Phenotype | 7 | 0.0 |
Polymorphism, Genetic | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 113 | 0.0 |
Adolescent | 7 | 0.0 |
Adult | 24 | 0.0 |
Base Sequence | 36 | 0.0 |
*Cell Proliferation | 2 | 12.0 |
Cells, Cultured | 45 | 0.0 |
Comparative Study | 13 | 0.0 |
Male | 43 | 0.0 |
Mesoderm/physiology | 4 | 11.0 |
Molecular Sequence Data | 56 | 0.0 |
Probability | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 240 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 27 | 0.0 |
Transforming Growth Factor beta/*metabolism | 53 | 23.0 |
Binding, Competitive | 5 | 0.0 |
Nuclear Proteins/metabolism | 5 | 0.0 |
Signal Transduction | 79 | 1.0 |
Transforming Growth Factor beta/*antagonists & inhibitors/physiology | 4 | 80.0 |
Animals | 157 | 0.0 |
Rats | 26 | 0.0 |
Amino Acid Sequence | 42 | 0.0 |
Chromosome Mapping | 9 | 0.0 |
Cloning, Molecular | 17 | 0.0 |
DNA-Binding Proteins/metabolism | 28 | 1.0 |
Gene Expression | 7 | 0.0 |
Gene Library | 2 | 0.0 |
Phosphorylation | 77 | 0.0 |
Signal Transduction/genetics | 7 | 2.0 |
Trans-Activators/metabolism | 32 | 3.0 |
Tumor Cells, Cultured | 61 | 0.0 |
Autocrine Communication/physiology | 2 | 7.0 |
Immunohistochemistry/methods | 2 | 0.0 |
Ovarian Follicle/*metabolism | 2 | 7.0 |
Reference Values | 3 | 0.0 |
*Signal Transduction | 36 | 1.0 |
Tissue Distribution | 5 | 0.0 |
Cell Movement/physiology | 3 | 1.0 |
Mice | 69 | 0.0 |
Signal Transduction/*physiology | 26 | 2.0 |
Transforming Growth Factor beta/*physiology | 21 | 16.0 |
Wound Healing/*physiology | 2 | 3.0 |
Activin Receptors, Type I/metabolism | 5 | 27.0 |
Cell Line | 81 | 0.0 |
DNA-Binding Proteins/*metabolism | 53 | 2.0 |
Receptors, Transforming Growth Factor beta/metabolism | 13 | 30.0 |
Trans-Activators/*metabolism | 54 | 5.0 |
COS Cells | 35 | 1.0 |
Enzyme Activation | 7 | 0.0 |
Glutathione Transferase/metabolism | 6 | 0.0 |
Immunoblotting | 10 | 0.0 |
Precipitin Tests | 15 | 0.0 |
Protein Binding | 41 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 7 | 0.0 |
Transcription Factor AP-1/metabolism | 3 | 1.0 |
*Transcription, Genetic | 4 | 0.0 |
Transfection | 60 | 0.0 |
Transforming Growth Factor beta/metabolism | 14 | 7.0 |
DNA Primers | 12 | 0.0 |
*Trans-Activation (Genetics) | 5 | 0.0 |
Trans-Activators/*antagonists & inhibitors/metabolism | 2 | 10.0 |
Two-Hybrid System Techniques | 7 | 0.0 |
Cell Division/physiology | 6 | 0.0 |
DNA-Binding Proteins/biosynthesis/physiology | 2 | 40.0 |
Frameshift Mutation | 2 | 0.0 |
Immunohistochemistry | 21 | 0.0 |
Middle Aged | 21 | 0.0 |
RNA, Messenger/biosynthesis/genetics | 3 | 0.0 |
Receptors, Transforming Growth Factor beta/biosynthesis/genetics | 3 | 60.0 |
Signal Transduction/physiology | 20 | 2.0 |
DNA-Binding Proteins/*genetics/metabolism | 6 | 1.0 |
Exons | 6 | 0.0 |
Genes, Dominant | 4 | 0.0 |
*Mutation | 9 | 0.0 |
Signal Transduction/genetics/physiology | 2 | 4.0 |
Trans-Activators/*genetics/metabolism | 6 | 5.0 |
Transforming Growth Factor beta/*pharmacology/physiology | 2 | 18.0 |
*Gene Expression | 3 | 0.0 |
Inhibin-beta Subunits/pharmacology | 2 | 28.0 |
Rats, Sprague-Dawley | 6 | 0.0 |
Transforming Growth Factor beta/pharmacology | 9 | 2.0 |
Extracellular Matrix/*metabolism | 2 | 2.0 |
Models, Molecular | 8 | 0.0 |
Sequence Homology, Amino Acid | 12 | 0.0 |
Transforming Growth Factor beta/genetics/*physiology | 3 | 21.0 |
Green Fluorescent Proteins | 4 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 3 | 0.0 |
Jurkat Cells | 3 | 0.0 |
Transcription, Genetic/drug effects | 8 | 1.0 |
Enzyme-Linked Immunosorbent Assay | 5 | 0.0 |
Trans-Activators/biosynthesis/genetics | 2 | 5.0 |
Activin Receptors, Type I/genetics/*metabolism | 2 | 40.0 |
Cattle | 4 | 0.0 |
Cell Division | 20 | 0.0 |
Cercopithecus aethiops | 5 | 0.0 |
DNA-Binding Proteins/genetics/metabolism | 9 | 1.0 |
Dose-Response Relationship, Drug | 17 | 0.0 |
Kinetics | 7 | 0.0 |
Phosphoproteins/metabolism | 4 | 0.0 |
Plasminogen Activator Inhibitor 1/genetics | 2 | 6.0 |
*Repressor Proteins | 5 | 0.0 |
Transcription Factors/genetics | 3 | 0.0 |
Transforming Growth Factor beta/*metabolism/pharmacology | 9 | 36.0 |
English Abstract | 4 | 0.0 |
Blotting, Western | 26 | 0.0 |
Phosphorylation/drug effects | 13 | 1.0 |
RNA, Messenger/genetics/metabolism | 6 | 0.0 |
Signal Transduction/drug effects | 10 | 1.0 |
Up-Regulation/drug effects | 2 | 0.0 |
Blotting, Northern | 17 | 0.0 |
Cell Cycle Proteins/biosynthesis/genetics | 2 | 10.0 |
Cell Division/drug effects | 14 | 0.0 |
DNA-Binding Proteins/*physiology | 14 | 2.0 |
Trans-Activators/*physiology | 14 | 5.0 |
Transforming Growth Factor beta/*pharmacology | 43 | 10.0 |
*Tumor Suppressor Proteins | 5 | 0.0 |
Mice, Inbred C57BL | 9 | 0.0 |
Cell Line, Transformed | 5 | 0.0 |
DNA-Binding Proteins/chemistry/*metabolism | 5 | 2.0 |
Enzyme Inhibitors/pharmacology | 10 | 0.0 |
Gene Expression Regulation/drug effects | 9 | 1.0 |
Luciferases/genetics | 4 | 1.0 |
Plasminogen Activator Inhibitor 1/*genetics | 4 | 11.0 |
Trans-Activators/chemistry/*metabolism | 6 | 9.0 |
Transforming Growth Factor beta/antagonists & inhibitors/*pharmacology | 4 | 30.0 |
Heterozygote | 4 | 0.0 |
Mice, Inbred BALB C | 6 | 0.0 |
Pregnancy | 4 | 0.0 |
Prognosis | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 12 | 0.0 |
Promoter Regions (Genetics) | 27 | 0.0 |
Receptors, Transforming Growth Factor beta/genetics/metabolism | 7 | 46.0 |
Amino Acid Motifs | 8 | 0.0 |
Binding Sites | 24 | 0.0 |
DNA-Binding Proteins/*chemistry/genetics/*metabolism | 2 | 3.0 |
Mutation/genetics | 4 | 0.0 |
Neoplasms/genetics | 4 | 3.0 |
Protein Structure, Quaternary | 2 | 1.0 |
Protein Structure, Tertiary | 21 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 4 | 0.0 |
Sequence Alignment | 6 | 0.0 |
Signal Transduction/*drug effects | 5 | 1.0 |
Structure-Activity Relationship | 6 | 0.0 |
Trans-Activators/*chemistry/genetics/*metabolism | 2 | 9.0 |
Actins/metabolism | 4 | 0.0 |
Cell Nucleus/metabolism | 18 | 0.0 |
Enzyme Activation/drug effects | 5 | 0.0 |
Epithelial Cells/drug effects/metabolism | 3 | 3.0 |
Fibroblasts/drug effects/metabolism | 2 | 1.0 |
MAP Kinase Signaling System/*drug effects | 2 | 5.0 |
Statistics, Nonparametric | 2 | 0.0 |
Tumor Cells, Cultured/drug effects | 2 | 0.0 |
Breast Neoplasms/*metabolism | 2 | 0.0 |
DNA, Complementary/metabolism | 7 | 0.0 |
Mutation | 25 | 0.0 |
Recombinant Proteins/metabolism | 8 | 0.0 |
Transforming Growth Factor beta/antagonists & | 2 | 33.0 |
Cycloheximide/pharmacology | 5 | 0.0 |
Dactinomycin/pharmacology | 3 | 0.0 |
Immediate-Early Proteins/metabolism | 2 | 6.0 |
Ligands | 12 | 0.0 |
Prostatic Neoplasms | 2 | 3.0 |
Protein Synthesis Inhibitors/pharmacology | 5 | 1.0 |
Proto-Oncogene Proteins c-fos/metabolism | 2 | 1.0 |
Transcription Factors/metabolism | 7 | 0.0 |
Clone Cells | 2 | 0.0 |
Gene Expression Regulation | 12 | 0.0 |
*Intracellular Signaling Peptides and Proteins | 8 | 1.0 |
Oligonucleotides, Antisense/pharmacology | 4 | 1.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Transcription, Genetic | 32 | 0.0 |
DNA-Binding Proteins/*chemistry/*metabolism | 4 | 6.0 |
Gene Deletion | 9 | 0.0 |
Models, Genetic | 7 | 0.0 |
Retroviridae/genetics | 3 | 0.0 |
Trans-Activators/*chemistry/*metabolism | 4 | 22.0 |
Ubiquitin/*metabolism | 2 | 1.0 |
Collagen/*genetics | 2 | 0.0 |
RNA, Messenger/metabolism | 17 | 0.0 |
3T3 Cells | 8 | 0.0 |
Alleles | 4 | 0.0 |
Loss of Heterozygosity | 10 | 1.0 |
Mesoderm/metabolism | 2 | 2.0 |
Plasmids/metabolism | 10 | 0.0 |
Xenopus | 11 | 2.0 |
*Xenopus Proteins | 19 | 5.0 |
*Serine Endopeptidases | 4 | 11.0 |
*Zinc Fingers | 3 | 1.0 |
*Receptors, Growth Factor | 2 | 6.0 |
Recombinant Fusion Proteins/chemistry/metabolism | 2 | 1.0 |
*MAP Kinase Kinase Kinase 1 | 2 | 1.0 |
*MAP Kinase Signaling System | 3 | 2.0 |
Mitogen-Activated Protein Kinase 1/*metabolism | 3 | 2.0 |
Mitogen-Activated Protein Kinase 3 | 4 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Protein-Tyrosine Kinase/antagonists & inhibitors | 2 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 11 | 1.0 |
Genetic Vectors | 5 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 8 | 0.0 |
Mutagenesis/physiology | 2 | 2.0 |
Transcription Factors/*metabolism | 8 | 0.0 |
Cell Differentiation | 7 | 0.0 |
DNA-Binding Proteins/*biosynthesis | 4 | 3.0 |
Ectoderm/metabolism | 2 | 8.0 |
Epidermis/*metabolism | 2 | 8.0 |
In Situ Hybridization | 3 | 0.0 |
Keratinocytes/*metabolism | 5 | 5.0 |
Mice, Transgenic | 5 | 0.0 |
RNA/metabolism | 5 | 1.0 |
Trans-Activators/*biosynthesis | 4 | 7.0 |
Up-Regulation | 5 | 0.0 |
Active Transport, Cell Nucleus | 9 | 3.0 |
Butadienes/pharmacology | 2 | 3.0 |
Flavonoids/pharmacology | 5 | 1.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
Furin | 2 | 4.0 |
MAP Kinase Kinase 1 | 4 | 2.0 |
Mitogen-Activated Protein Kinase Kinases/metabolism | 2 | 1.0 |
Nitriles/pharmacology | 2 | 1.0 |
*Alleles | 3 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Chromosomes, Human, Pair 18/*genetics | 11 | 14.0 |
Genes, DCC/genetics | 2 | 25.0 |
Trans-Activators/genetics/metabolism | 7 | 4.0 |
DNA-Binding Proteins/genetics/*metabolism | 21 | 2.0 |
Liver Neoplasms | 2 | 0.0 |
Promoter Regions (Genetics)/physiology | 5 | 3.0 |
RNA, Messenger/analysis | 13 | 0.0 |
Trans-Activators/genetics/*metabolism | 20 | 5.0 |
DNA, Neoplasm/biosynthesis | 2 | 1.0 |
Disease Progression | 6 | 0.0 |
Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors | 2 | 4.0 |
Neoplasm Proteins/*metabolism | 2 | 0.0 |
Protein Processing, Post-Translational/*drug effects | 2 | 3.0 |
DNA Mutational Analysis | 10 | 0.0 |
Image Processing, Computer-Assisted | 2 | 0.0 |
Polymerase Chain Reaction | 16 | 0.0 |
Protein-Serine-Threonine Kinases/*metabolism | 6 | 0.0 |
DNA-Binding Proteins/genetics | 10 | 1.0 |
Gene Silencing | 4 | 1.0 |
*Genes, Tumor Suppressor | 13 | 1.0 |
*Loss of Heterozygosity | 2 | 0.0 |
Microsatellite Repeats/genetics | 2 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Trans-Activators/genetics | 12 | 5.0 |
Chromosome Deletion | 2 | 0.0 |
Colorectal Neoplasms/*genetics | 4 | 1.0 |
DNA-Binding Proteins/*genetics | 20 | 1.0 |
Trans-Activators/*genetics | 16 | 4.0 |
Transforming Growth Factor beta/genetics | 5 | 5.0 |
Mink | 12 | 18.0 |
Ubiquitin-Protein Ligases | 5 | 2.0 |
Ubiquitins/metabolism | 3 | 2.0 |
Receptors, Transforming Growth Factor beta/*physiology | 4 | 40.0 |
Recombinant Fusion Proteins/metabolism | 7 | 0.0 |
Transforming Growth Factor beta/pharmacology/*physiology | 5 | 20.0 |
Cell Cycle/physiology | 2 | 0.0 |
Mitogen-Activated Protein Kinases/physiology | 2 | 1.0 |
Transforming Growth Factor beta/physiology | 13 | 13.0 |
*Gene Expression Regulation | 8 | 0.0 |
Mitogen-Activated Protein Kinases/*metabolism | 5 | 0.0 |
Protein-Serine-Threonine Kinases/genetics | 2 | 1.0 |
Cell Transformation, Neoplastic | 3 | 0.0 |
Genes, Tumor Suppressor | 10 | 1.0 |
Isopropyl Thiogalactoside/pharmacology | 2 | 11.0 |
Protein Transport | 8 | 1.0 |
Signal Transduction/drug effects/*physiology | 4 | 1.0 |
Thymidine/metabolism | 4 | 1.0 |
Transcription, Genetic/*drug effects | 3 | 0.0 |
Adenocarcinoma/pathology | 2 | 2.0 |
Hela Cells | 11 | 0.0 |
Histones/metabolism | 2 | 0.0 |
Mice, Knockout | 8 | 0.0 |
Cell Transformation, Neoplastic/genetics | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 10 | 0.0 |
Transforming Growth Factor beta/*genetics | 3 | 3.0 |
Carrier Proteins/metabolism | 2 | 0.0 |
Cell Nucleus/*metabolism | 4 | 0.0 |
Nuclear Proteins/*metabolism | 2 | 0.0 |
Luciferases/genetics/metabolism | 2 | 0.0 |
Phosphates/metabolism | 3 | 3.0 |
Phosphoproteins/*metabolism | 4 | 0.0 |
Transforming Growth Factor beta/genetics/*metabolism/pharmacology | 3 | 100.0 |
Amino Acid Substitution | 4 | 0.0 |
CHO Cells | 5 | 0.0 |
Hamsters | 6 | 0.0 |
Mutagenesis, Site-Directed | 9 | 0.0 |
Protein Processing, Post-Translational | 4 | 0.0 |
Recombinant Proteins/chemistry/metabolism | 3 | 0.0 |
Activins | 14 | 19.0 |
Carrier Proteins/*metabolism | 2 | 0.0 |
Cytoplasm/metabolism | 5 | 0.0 |
Inhibins/metabolism | 2 | 13.0 |
Luminescent Proteins/metabolism | 2 | 0.0 |
Microscopy, Fluorescence | 5 | 0.0 |
*Cell Cycle Proteins | 2 | 0.0 |
Repressor Proteins/metabolism | 5 | 2.0 |
Transcription, Genetic/physiology | 6 | 3.0 |
Homeodomain Proteins/*metabolism | 2 | 1.0 |
ras Proteins/*metabolism | 2 | 1.0 |
Receptors, Transforming Growth Factor beta/physiology | 3 | 30.0 |
Cysteine Proteinase Inhibitors/pharmacology | 2 | 0.0 |
Substrate Specificity | 2 | 0.0 |
Xenopus laevis | 3 | 0.0 |
DNA/metabolism | 11 | 0.0 |
DNA-Binding Proteins/*genetics/*physiology | 2 | 5.0 |
*Promoter Regions (Genetics) | 5 | 0.0 |
Trans-Activators/*genetics/*physiology | 2 | 16.0 |
Rabbits | 3 | 0.0 |
DNA, Neoplasm/genetics | 3 | 0.0 |
Melanoma/genetics/*metabolism | 2 | 12.0 |
Microsatellite Repeats | 4 | 0.0 |
Transforming Growth Factor beta/genetics/*metabolism | 4 | 10.0 |
Gene Targeting | 3 | 0.0 |
Subcellular Fractions/metabolism | 2 | 0.0 |
Apoptosis | 5 | 0.0 |
Mesoderm/*metabolism | 2 | 6.0 |
Escherichia coli | 2 | 0.0 |
*Active Transport, Cell Nucleus | 2 | 5.0 |
Alternative Splicing | 2 | 0.0 |
Protein Isoforms/genetics/metabolism | 2 | 1.0 |
DNA-Binding Proteins/analysis/*genetics/metabolism | 2 | 25.0 |
Epithelial Cells/metabolism | 2 | 0.0 |
Lung | 5 | 5.0 |
Mutagenesis | 3 | 0.0 |
Trans-Activators/analysis/*genetics/metabolism | 2 | 66.0 |
Caco-2 Cells | 2 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
*Genes, DCC | 2 | 5.0 |
HT29 Cells | 2 | 1.0 |
*Activin Receptors, Type I | 8 | 32.0 |
Loss of Heterozygosity/*genetics | 2 | 2.0 |
Polymorphism, Single-Stranded Conformational | 12 | 0.0 |
Receptors, Transforming Growth Factor beta/genetics | 4 | 7.0 |
rho GTP-Binding Proteins/metabolism | 2 | 2.0 |
Cell Transformation, Neoplastic/*metabolism | 2 | 5.0 |
Disease Models, Animal | 3 | 0.0 |
Lung/*metabolism | 2 | 2.0 |
Nuclear Proteins/genetics/*metabolism | 2 | 0.0 |
Transcription Factors/genetics/*metabolism | 4 | 0.0 |
Neoplasm Invasiveness | 4 | 0.0 |
Receptors, Transforming Growth Factor beta/*metabolism | 9 | 33.0 |
Thyroid Neoplasms/*metabolism/pathology | 2 | 4.0 |
DNA-Binding Proteins/chemistry/genetics/*metabolism | 6 | 3.0 |
Protein Binding/drug effects | 2 | 0.0 |
Trans-Activators/chemistry/genetics/*metabolism | 5 | 6.0 |
DNA-Binding Proteins/chemistry/*physiology | 2 | 6.0 |
Protein Conformation | 3 | 0.0 |
Trans-Activators/chemistry/*physiology | 2 | 11.0 |
Transcription Factors/*physiology | 4 | 0.0 |
Transcription, Genetic/*physiology | 3 | 1.0 |
Trans-Activators/*antagonists & inhibitors/physiology | 2 | 33.0 |
Cell Line, Tumor | 12 | 0.0 |
*Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Body Patterning | 2 | 3.0 |
Bone Morphogenetic Proteins/metabolism | 2 | 3.0 |
DNA-Binding Proteins/chemistry/genetics/metabolism | 2 | 6.0 |
Gene Expression Regulation, Developmental | 9 | 0.0 |
Trans-Activators/chemistry/genetics/metabolism | 2 | 18.0 |
Xenopus/*embryology | 2 | 11.0 |
Chromosome Aberrations | 2 | 0.0 |
Chromosomes, Human, Pair 5 | 2 | 1.0 |
Leukemia, Myelocytic, Acute/*genetics | 2 | 1.0 |
Phosphoproteins/*genetics | 3 | 1.0 |
Cell Cycle | 4 | 0.0 |
Flow Cytometry | 3 | 0.0 |
NF-kappa B/*physiology | 2 | 2.0 |
Chromosomes, Human, Pair 18/genetics | 2 | 4.0 |
*Apoptosis | 4 | 0.0 |
Chondrocytes/*metabolism | 2 | 6.0 |
Esophageal Neoplasms/*genetics | 2 | 2.0 |
Receptors, Transforming Growth Factor beta/*genetics | 5 | 11.0 |
Conserved Sequence | 3 | 0.0 |
Pancreatic Neoplasms/genetics | 2 | 5.0 |
Proteasome Endopeptidase Complex | 2 | 0.0 |
Trans-Activation (Genetics) | 12 | 0.0 |
Ubiquitins/*metabolism | 2 | 1.0 |
Adenocarcinoma/*genetics | 2 | 1.0 |
Genes, Tumor Suppressor/*physiology | 2 | 1.0 |
Genes, ras/*physiology | 2 | 7.0 |
Sensitivity and Specificity | 2 | 0.0 |
Plasmids | 2 | 0.0 |
*Proteins | 2 | 0.0 |
Receptors, Growth Factor/metabolism | 3 | 2.0 |
*Chromosome Deletion | 2 | 0.0 |
Genetic Markers | 5 | 0.0 |
Polymerase Chain Reaction/methods | 3 | 0.0 |
Embryonic and Fetal Development | 2 | 0.0 |
Mammals | 2 | 0.0 |
Transforming Growth Factor beta/genetics/metabolism | 4 | 11.0 |
Colorectal Neoplasms/*genetics/pathology | 3 | 3.0 |
DNA-Binding Proteins/*genetics/physiology | 2 | 2.0 |
Mice, Nude | 4 | 0.0 |
Neoplasm Transplantation | 4 | 0.0 |
Pancreatic Neoplasms/*genetics/pathology | 2 | 5.0 |
Transplantation, Heterologous | 2 | 0.0 |
DNA-Binding Proteins/*metabolism/physiology | 2 | 5.0 |
Gene Expression Regulation, Developmental/*physiology | 3 | 2.0 |
Inhibins/physiology | 2 | 66.0 |
Macromolecular Substances | 8 | 0.0 |
Mesoderm/*physiology | 2 | 8.0 |
DNA-Binding Proteins/chemistry/*genetics | 2 | 2.0 |
Trans-Activators/chemistry/*genetics | 3 | 16.0 |
Genes, APC | 2 | 2.0 |
Genes, DCC | 3 | 15.0 |
In Vitro | 5 | 0.0 |
*Protein-Serine-Threonine Kinases | 2 | 0.0 |
Trans-Activators | 2 | 4.0 |
DNA-Binding Proteins/metabolism/*physiology | 4 | 3.0 |
Trans-Activators/metabolism/*physiology | 3 | 5.0 |
Ubiquitin/metabolism | 3 | 1.0 |
Fluorescent Antibody Technique | 5 | 0.0 |
DNA/*metabolism | 2 | 0.0 |
*Nuclear Proteins | 2 | 0.0 |
Genes, Lethal | 2 | 2.0 |
Heart/embryology | 3 | 5.0 |
Homozygote | 3 | 0.0 |
Morphogenesis | 2 | 0.0 |
Activin Receptors | 3 | 16.0 |
Inhibins/*pharmacology | 2 | 18.0 |
Response Elements | 3 | 1.0 |
Proto-Oncogene Proteins/genetics/*metabolism | 2 | 0.0 |
Pancreas/metabolism | 2 | 2.0 |
Pancreatic Neoplasms/*metabolism | 2 | 2.0 |
Glomerular Mesangium/cytology/*physiology | 2 | 22.0 |
Signal Transduction/*drug effects/physiology | 2 | 3.0 |
Transforming Growth Factor beta/metabolism/*pharmacology | 2 | 18.0 |
Gene Frequency | 2 | 0.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/metabolism | 2 | 1.0 |
Embryo, Nonmammalian/metabolism | 5 | 12.0 |
Embryonic Development | 2 | 5.0 |
Xenopus/embryology | 3 | 23.0 |
Bone Morphogenetic Proteins/*metabolism | 4 | 9.0 |
Chromosome Banding | 2 | 0.0 |
DNA-Binding Proteins/biosynthesis/*genetics | 2 | 1.0 |
Loss of Heterozygosity/genetics | 2 | 1.0 |
Adenomatous Polyposis Coli/*genetics | 2 | 3.0 |
Child | 3 | 0.0 |
DNA-Binding Proteins/genetics/*physiology | 3 | 1.0 |
Trans-Activators/genetics/*physiology | 4 | 4.0 |
Down-Regulation | 7 | 0.0 |
Growth Substances/metabolism | 2 | 1.0 |
Oxidation-Reduction | 2 | 0.0 |
Species Specificity | 2 | 0.0 |
Signal Transduction/drug effects/physiology | 2 | 0.0 |
Pancreatic Neoplasms/*genetics | 2 | 2.0 |
Adenoviridae/genetics | 2 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Genetic Vectors/genetics | 2 | 0.0 |
Recombinant Fusion Proteins/physiology | 3 | 1.0 |
*Transfection | 2 | 0.0 |
DNA-Binding Proteins/*biosynthesis/genetics | 2 | 2.0 |
Trans-Activators/*biosynthesis/genetics | 2 | 7.0 |
Activins/*pharmacology | 2 | 33.0 |
Gene Expression Regulation, Neoplastic/drug effects | 3 | 0.0 |
Regulatory Sequences, Nucleic Acid | 2 | 0.0 |
DNA-Binding Proteins/genetics/metabolism/*physiology | 2 | 3.0 |
Epithelial Cells | 3 | 0.0 |
Trans-Activators/genetics/metabolism/*physiology | 2 | 7.0 |
Transcription Factors/physiology | 2 | 0.0 |
Transforming Growth Factor beta/antagonists & inhibitors/*metabolism | 3 | 30.0 |
Biological Transport | 2 | 0.0 |
Recombinant Fusion Proteins/biosynthesis | 2 | 0.0 |
Point Mutation | 5 | 0.0 |
Activin Receptors, Type I | 2 | 40.0 |
Signal Transduction/*genetics | 2 | 1.0 |
Epithelial Cells/*metabolism | 2 | 1.0 |
Activin Receptors, Type I/*metabolism | 2 | 25.0 |
Cell Division/drug effects/physiology | 2 | 0.0 |
Fibrosis | 3 | 2.0 |
Epitopes | 2 | 0.0 |
Recombinant Proteins/genetics/metabolism | 2 | 0.0 |
Subcellular Fractions | 3 | 1.0 |
Cell Differentiation/drug effects | 6 | 0.0 |
*Chromosomes, Human, Pair 18 | 3 | 2.0 |
Consensus Sequence | 2 | 0.0 |
*DNA-Binding Proteins | 3 | 0.0 |
*Embryonic Induction | 2 | 9.0 |
Transcription Factors/*genetics | 2 | 0.0 |
Cell Survival | 2 | 0.0 |
Epithelial Cells/*cytology/metabolism | 2 | 12.0 |
Antibody Specificity | 2 | 0.0 |
Mice, Mutant Strains | 2 | 0.0 |
Survival Analysis | 2 | 0.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 2 | 0.0 |
Carcinoma, Small Cell/*genetics | 2 | 3.0 |
Lung Neoplasms/*genetics | 3 | 1.0 |
*Trans-Activators | 11 | 1.0 |
Recombinant Fusion Proteins/genetics/metabolism | 5 | 0.0 |
Chromosomes, Human, Pair 18 | 3 | 2.0 |
RNA, Neoplasm/genetics | 3 | 0.0 |
Recombinant Proteins/chemistry/genetics/metabolism | 2 | 0.0 |
Platelet-Derived Growth Factor/pharmacology | 2 | 1.0 |
Inhibins/genetics/metabolism | 2 | 100.0 |
Embryo | 2 | 0.0 |
Protein-Serine-Threonine Kinases/genetics/metabolism | 4 | 3.0 |
Trans-Activators/physiology | 5 | 3.0 |
Bone Morphogenetic Proteins/*pharmacology | 2 | 3.0 |
Introns | 3 | 0.0 |
RNA, Messenger/genetics | 5 | 0.0 |
Transcription Factors/genetics/metabolism | 2 | 0.0 |
Fibroblasts/cytology/metabolism | 2 | 1.0 |
Adenoviridae/genetics/metabolism | 2 | 6.0 |
Cell Separation | 2 | 0.0 |
RNA, Small Interfering/metabolism | 5 | 2.0 |
Saccharomyces cerevisiae/genetics | 2 | 0.0 |
Breast Neoplasms/genetics/metabolism | 2 | 4.0 |
Activins/genetics/*metabolism | 2 | 100.0 |
Cell Adhesion/physiology | 2 | 0.0 |
Actins/genetics | 2 | 1.0 |
Infant, Newborn | 2 | 0.0 |
Cholecalciferol/pharmacology | 2 | 6.0 |
Child, Preschool | 2 | 0.0 |
Infant | 3 | 0.0 |
Cell Differentiation/*physiology | 3 | 1.0 |
Keratinocytes/cytology/*metabolism | 2 | 5.0 |
Cell Movement/drug effects | 2 | 0.0 |
Dimerization | 3 | 0.0 |
Cell Proliferation/drug effects | 2 | 2.0 |
Receptors, Transforming Growth Factor beta/*antagonists & inhibitors | 2 | 50.0 |
Protein Transport/drug effects | 2 | 3.0 |
Recombinant Proteins/pharmacology | 4 | 0.0 |
Cell Differentiation/physiology | 3 | 0.0 |
Transduction, Genetic | 2 | 0.0 |
Transforming Growth Factor beta/*antagonists & inhibitors | 3 | 23.0 |
Drug Resistance | 2 | 0.0 |
DNA-Binding Proteins/physiology | 3 | 1.0 |
Electrophoresis, Polyacrylamide Gel | 4 | 0.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
Gene Expression Profiling | 2 | 0.0 |
Autocrine Communication/*physiology | 2 | 7.0 |
Receptor, Epidermal Growth Factor/*metabolism | 2 | 0.0 |
Activins/metabolism | 2 | 28.0 |
Activin Receptors, Type I/genetics/metabolism | 4 | 57.0 |
Glomerular Mesangium/metabolism | 2 | 25.0 |
Alkaline Phosphatase/metabolism | 2 | 1.0 |
Activins/*metabolism | 2 | 25.0 |
Down-Regulation/drug effects | 2 | 0.0 |
Cytoplasm/*metabolism | 3 | 2.0 |
Gene Expression/physiology | 2 | 0.0 |
Embryo/cytology | 2 | 2.0 |
DNA-Binding Proteins/antagonists & inhibitors/genetics/*metabolism | 2 | 9.0 |
Trans-Activators/antagonists & inhibitors/genetics/*metabolism | 2 | 14.0 |
